Novel lipase

By designing a novel lipase with characteristics of proteoglossium/Yelsenia clade, the problem of low surfactant inhibition and heterologous expression manufacturing efficiency was solved, and high activity and excellent cleaning performance were achieved.

CN119095965APending Publication Date: 2024-12-06KAO CORP
View PDF 9 Cites 0 Cited by

Patent Information

Application Number
CN202380033825.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-13
Filing Date
2023-04-12
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The activity of existing lipases is significantly inhibited in the presence of surfactants, affecting cleaning performance, and there are challenges in low-cost manufacturing of heterologous expression.

Method used

A novel lipase has been developed with high identity to the ancestors of the Proteobacter/Yelsenia clade, able to maintain high activity in the presence of surfactants, and through phylogenetic tree design and multiple ratios A lipase sequence with excellent cleaning performance was inferred.

Benefits of technology

The novel lipase significantly improves the resistance to inhibition of surfactant activity and shows high cleaning effects in the detergent composition, solving the problems of activity inhibition and manufacturing efficiency in the prior art.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095965A_ABST
    Figure CN119095965A_ABST
Patent Text Reader

Abstract

The present invention provides a lipase which mitigates activity inhibition by a surfactant and exhibits a high cleaning effect. The lipase is composed of an amino acid sequence represented by SEQ ID NO: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44, or an amino acid sequence having at least a considerable degree of identity with any of these sequences.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a novel lipase. Background Art

[0002] Lipase is useful in various applications such as washing detergents, dishwashing detergents, oil processing, pulp processing, feed, and synthesis of pharmaceutical intermediates. In cleaning, lipase hydrolyzes triglycerides to generate fatty acids, thereby contributing to the removal of oil-containing dirt.

[0003] Existing cleaning compositions or cleaning environments contain various ingredients that inhibit the activity or cleaning effect of lipases, and lipases that function under such conditions are required. As a lipase useful for cleaning, a lipase from Thermomyces lanuginosus (hereinafter referred to as TLL) is sold under the trade name of LIPOLASE (registered trademark). Patent document 1 discloses that the lipase Lipr139 from Cedecea sp-16640 strain has a cleaning performance superior to TLL. Patent document 2 discloses a mutant of a lipase from a Proteus bacterium (hereinafter referred to as PvLip) having improved cleaning performance when compared with one or more reference lipolytic enzymes. Patent document 3 discloses that the lipase Lipr138 from a metagenome has a cleaning performance superior to TLL. Lipr139, PvLip, and Lipr138 are lipases belonging to the same clade (Proteus / Yersinia clade) including lipases from bacteria of the genus Proteus or Yersinia .

[0004] Many lipases from Gram-negative bacteria require lipase-specific partners to fold into active forms (non-patent literature 1), which has problems in low-cost manufacturing by heterologous expression. It has been reported that heterologous expression is improved by co-expression of specific partners (non-patent literature 2), but its productivity is low, and there are still large problems in low-cost manufacturing by heterologous expression. On the other hand, bacterial lipases of Proteus / Yersinia clades do not require specific partners, and have advantages in low-cost manufacturing by heterologous expression (non-patent literature 3, 4).

[0005] As described above, bacterial lipases of the Proteus / Yersinia clade have great potential as cleaning enzymes in terms of both their suitability for cleaning and the possibility of low-cost production.

[0006] (Patent Document 1) Japanese Patent Publication No. 2015-523078

[0007] (Patent Document 2) International Publication No. 2020 / 046613

[0008] (Patent Document 3) Japanese Patent Publication No. 2015-525248

[0009] (Non-patent document 1) Hobson, Audrey H., et al. Proceedings of the National Academy of Sciences 90.12(1993):5682-5686.

[0010] (Non-patent document 2) Quyen, Thi Dinh, Chi Hai Vu, and Giang Thi Thu Le. Microbial cell factories 11.1 (2012): 1-12.

[0011] (Non-patent document 3) Lee, Hong-Weon, et al. Biotechnology letters 22.19 (2000): 1543-1547.

[0012] (Non-patent document 4) Glogauer, Arnaldo, et al. Microbial cell factories 10.1 (2011): 1-15. Summary of the invention

[0013] The present invention relates to the following 1) to 6).

[0014] 1) Any of the following lipases:

[0015] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 14 or an amino acid sequence having at least 79% identity thereto;

[0016] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 16 or an amino acid sequence having at least 76% identity thereto;

[0017] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 81% identity thereto;

[0018] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 20 or an amino acid sequence having at least 83% identity thereto;

[0019] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 22 or an amino acid sequence having at least 96% identity thereto;

[0020] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 83% identity thereto;

[0021] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 26 or an amino acid sequence having at least 90% identity thereto;

[0022] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 28 or an amino acid sequence having at least 82% identity thereto;

[0023] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 30 or an amino acid sequence having at least 73% identity thereto;

[0024] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 32 or an amino acid sequence having at least 73% identity thereto;

[0025] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 34 or an amino acid sequence having at least 79% identity thereto;

[0026] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 36 or an amino acid sequence having at least 85% identity thereto;

[0027] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 38 or an amino acid sequence having at least 73% identity thereto;

[0028] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 40 or an amino acid sequence having at least 71% identity thereto;

[0029] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 42 or an amino acid sequence having at least 72% identity thereto; and

[0030] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 44 or an amino acid sequence having at least 70% identity thereto.

[0031] 2) A polynucleotide encoding the lipase described in 1).

[0032] 3) A vector or a DNA fragment comprising the polynucleotide of 2).

[0033] 4) A transformed cell containing the vector or DNA fragment of 3).

[0034] 5) A cleaning composition comprising the lipase described in 1).

[0035] 6) A method for cleaning dirt, comprising using the cleaning composition described in 5). BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 is the lipase activity of each lipase in surfactant solution.

[0037] Figure 2 is the lipase activity of each lipase in a model cleaning solution containing surfactant.

[0038] Figure 3 is the cleaning power of each lipase in a model cleaning solution containing surfactant.

[0039] Figure 4 It is the result of systematic analysis of various lipases. DETAILED DESCRIPTION

[0040] All patent documents, non-patent documents, and other publications cited in this specification are incorporated herein by reference in their entirety.

[0041] In this specification, "lipase" refers to triacylglycerol lipase (EC3.1.1.3), which means an enzyme group having the activity of hydrolyzing triglycerides to generate fatty acids. The lipase activity can be determined by measuring the rate of increase in the absorbance of free 4-nitrophenol obtained by hydrolysis of 4-nitrophenyloctanoate. The specific steps of measuring lipase activity are described in detail in the examples described below.

[0042] In the present specification, "lipase inferred to be possessed by an ancestral organism" refers to a lipase composed of an amino acid sequence derived from the amino acid sequence of lipases of various organisms derived from a common ancestor (also referred to as ancestral lipase) based on a rooted phylogenetic tree representing the evolution of proteins. The ancestral lipase can be designed by obtaining homologous sequences of lipases from public databases, etc., performing multiple alignments using the obtained homologous sequences, and then making a rooted phylogenetic tree, and using an ancestral sequence design method (Ancestral sequence reconstruction (Ancestral sequence reconstruction: ASR)) program to infer the amino acid sequence of the lipase of the common ancestor.

[0043] The design of ancestral lipase can use the usual method, for example, Merkl R, Sterner R., Biol Chem. 2016; 397 (1): 1-21 or Scossa F, Fernie AR., Comput Struct Biotechnol J. 2021; 19: 1579-1594, etc. The usual method of system analysis described in JSBi Bioinformatics Review, 2 (1), 30-57 (2021) can also be used. The data set of lipase homologous sequences can be obtained from public databases such as NCBI and UniProtKB by BLAST (Altschul et al., 1990). Alternatively, it can be obtained as a family from a domain database such as InterPro or Pfam at one time. Multiple alignments can be prepared using programs such as Clustal X and Clustal W (Larkin et al., 2007), MUSCLE (Edgar, 2004), MAFFT (Katohand Standley, 2013), MAFFT-DASH (Rozewicki et al., 2019), PRANK (Loytynoja, 2014), T-COFFEE (Notredame et al., 2000), etc. The prepared multiple alignments are appropriately trimmed using programs such as GBLOCKS (Castresana, 2000) or trimAl (Capella-Gutierrez et al., 2009) and used for phylogenetic tree estimation. Phylogenetic trees can be estimated using the maximum parsimony method, the Bayesian method, or the maximum likelihood method, and programs such as MrBayes (Ronquist et al., 2012), BEAST (Bouckaert et al., 2019), FastTree (Price et al., 2010), PhyML (Guindon et al., 2010), RAxML (Stamatakis et al., 2014), and IQ-TREE (Nguyen et al., 2015) can be used. Appropriate evolutionary models used in phylogenetic tree estimation can be selected using programs such as modeltest-ng (Darriba, D. et al., 2020) or ModelFinder (Kalyaanamoorthy et al., 2017).Ancestral sequence design can be performed using a dedicated program, such as FastML (Pupko et al., 2000), ProtASR2 (Arenas M and Bastolla, 2020), GRASP (Gabriel et al., 2019), etc. In addition, there are programs that include ancestral sequence design as part of the function of phylogenetic tree inference programs, and programs such as PAML (Yang, 1997), RAxML, and IQ-TREE can also be used. As a comprehensive environment for performing ancestral sequence design from these systematic analyses at one time, MEGA (Tamura et al., 2021) can also be used.

[0044] In this specification, the "Proteus / Yersinia evolutionary branch" refers to an evolutionary branch that includes lipases from Proteus and Yersinia bacteria (for example, sequence numbers 4 and 12) on a rooted phylogenetic tree, and the amino acid sequences shown in sequence numbers 2, 4, 6, 8, 10, 12 and 46 are all existing lipase sequences belonging to the Proteus / Yersinia evolutionary branch.

[0045] In the present specification, the identity of amino acid sequences or nucleotide sequences is calculated by the Lipman-Pearson method (Science, 1985, 227: 1435-1441). Specifically, the identity is calculated by using the homology analysis (Search homology) program of the genetic information processing software GENETYX Ver.12, and setting the Unit size to compare (ktup) to 2.

[0046] In this specification, "operably linked" between a control region such as a promoter and a gene means that the gene is linked to the control region so that the gene can be expressed under the control of the control region. The steps of "operably linking" a gene to a control region are well known to those skilled in the art.

[0047] In this specification, "upstream" and "downstream" of a gene refer to the upstream and downstream of the transcription direction of the gene. For example, "a gene located downstream of a promoter" means that the gene is present on the 3' side of the promoter in the sense strand of DNA, and the upstream of a gene refers to the region on the 5' side of the gene in the sense strand of DNA.

[0048] It is known that lipase is inhibited in activity by the surfactant contained in the cleaning composition. According to the actual verification by the inventors, among the known lipases that disclose the adaptability to cleaning, TLL, Lipr139 and PvLip are all greatly inhibited in activity due to the coexistence of surfactants. The activity inhibition caused by surfactants is a common major problem of cleaning lipases. In addition, lipases are not limited to cleaning applications, and are also often used together with surfactants in industrial applications such as pulp processing. The activity inhibition caused by surfactants is also a topic for industrial lipases as a whole. Therefore, it is required to have a lipase whose activity inhibition caused by surfactants is alleviated and shows a high cleaning effect.

[0049] The present inventors conducted intensive studies on this subject and found that a novel lipase sequence group possessed by an ancestral organism that is presumed to be a source of existing lipases belonging to the Proteus / Yersinia evolutionary branch surprisingly shows significantly high resistance to activity inhibition by surfactants and has remarkable cleaning performance.

[0050] It is generally known that ancestral enzymes have characteristics such as high heat resistance and high optimum temperature, but the characteristics related to activity inhibition by surfactants and the characteristics related to cleaning action at low temperatures have been completely unknown so far, and the above results are unexpected.

[0051] The lipase of the present invention has a remarkably high resistance to activity inhibition by surfactants, and exhibits an excellent cleaning effect even in the presence of surfactants.

[0052] <1. Lipase>

[0053] The lipase of the present invention is any one of the following lipases:

[0054] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 14 or an amino acid sequence having at least 79% identity thereto;

[0055] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 16 or an amino acid sequence having at least 76% identity thereto;

[0056] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 81% identity thereto;

[0057] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 20 or an amino acid sequence having at least 83% identity thereto;

[0058] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 22 or an amino acid sequence having at least 96% identity thereto;

[0059] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 83% identity thereto;

[0060] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 26 or an amino acid sequence having at least 90% identity thereto;

[0061] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 28 or an amino acid sequence having at least 82% identity thereto;

[0062] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 30 or an amino acid sequence having at least 73% identity thereto;

[0063] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 32 or an amino acid sequence having at least 73% identity thereto;

[0064] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 34 or an amino acid sequence having at least 79% identity thereto;

[0065] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 36 or an amino acid sequence having at least 85% identity thereto;

[0066] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 38 or an amino acid sequence having at least 73% identity thereto;

[0067] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 40 or an amino acid sequence having at least 71% identity thereto;

[0068] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 42 or an amino acid sequence having at least 72% identity thereto; and

[0069] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 44 or an amino acid sequence having at least 70% identity thereto.

[0070] Here, the amino acid sequence shown in any one of sequence numbers 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44 is a novel lipase sequence possessed by an ancestral organism of the source bacteria of existing lipases presumed to belong to the Proteus / Yersinia clade. It is generally known that ancestral enzymes show characteristics such as high heat resistance and high optimum temperature, but the characteristics related to the activity inhibition caused by surfactants and the characteristics related to the cleaning effect are completely unknown so far. The lipase of the present invention has a significantly high resistance to the lipase activity inhibition caused by surfactants and also shows a significantly high cleaning power in the presence of surfactants, which is completely unexpected.

[0071] Examples of lipases composed of an amino acid sequence having at least 79% identity to the amino acid sequence shown in SEQ ID NO: 14 include lipases composed of an amino acid sequence having at least 79% identity to the amino acid sequence shown in SEQ ID NO: 14, specifically 79% or more, preferably 82% or more, more preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 79% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0072] Examples of lipases composed of an amino acid sequence having at least 76% identity to the amino acid sequence shown in SEQ ID NO: 16 include lipases composed of an amino acid sequence having at least 76% identity to the amino acid sequence shown in SEQ ID NO: 16, specifically 76% or more, preferably 80% or more, more preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 76% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0073] Examples of lipases composed of an amino acid sequence having at least 81% identity to the amino acid sequence shown in SEQ ID NO: 18 include lipases composed of an amino acid sequence having at least 81% identity to the amino acid sequence shown in SEQ ID NO: 18, specifically 81% or more, preferably 85% or more, more preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 81% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0074] Examples of lipases composed of an amino acid sequence having at least 83% identity to the amino acid sequence shown in SEQ ID NO: 20 include lipases composed of an amino acid sequence having at least 83% identity to the amino acid sequence shown in SEQ ID NO: 20, specifically 83% or more, preferably 85% or more, more preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 83% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0075] Examples of lipases composed of an amino acid sequence having at least 96% identity with the amino acid sequence shown in SEQ ID NO: 22 include lipases composed of an amino acid sequence having at least 96% identity, specifically 96% or more, preferably 97% or more, more preferably 98% or more, and even more preferably 99% or more identity with the amino acid sequence shown in SEQ ID NO: 22. Amino acid sequences having at least 96% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0076] Examples of lipases composed of an amino acid sequence having at least 83% identity to the amino acid sequence shown in SEQ ID NO: 24 include lipases composed of an amino acid sequence having at least 83% identity to the amino acid sequence shown in SEQ ID NO: 24, specifically 83% or more, preferably 85% or more, more preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 83% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0077] Examples of lipases composed of an amino acid sequence having at least 90% identity with the amino acid sequence shown in SEQ ID NO: 26 include lipases composed of an amino acid sequence having at least 90% identity, specifically 90% or more, preferably 93% or more, more preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more, with the amino acid sequence shown in SEQ ID NO: 26. Amino acid sequences having at least 90% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0078] Examples of lipases composed of an amino acid sequence having at least 82% identity to the amino acid sequence shown in SEQ ID NO: 28 include lipases composed of an amino acid sequence having at least 83% identity to the amino acid sequence shown in SEQ ID NO: 28, specifically 82% or more, preferably 85% or more, more preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 82% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0079] Examples of lipases composed of an amino acid sequence having at least 73% identity to the amino acid sequence shown in SEQ ID NO: 30 include lipases composed of an amino acid sequence having at least 73% identity to the amino acid sequence shown in SEQ ID NO: 30, specifically 73% or more, preferably 75% or more, more preferably 80% or more, further preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 73% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0080] Examples of lipases composed of an amino acid sequence having at least 73% identity to the amino acid sequence shown in SEQ ID NO: 32 include lipases composed of an amino acid sequence having at least 73% identity to the amino acid sequence shown in SEQ ID NO: 32, specifically 73% or more, preferably 75% or more, more preferably 80% or more, further preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 73% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0081] Examples of lipases composed of an amino acid sequence having at least 79% identity to the amino acid sequence shown in SEQ ID NO: 34 include lipases composed of an amino acid sequence having at least 79% identity to the amino acid sequence shown in SEQ ID NO: 34, specifically 79% or more, preferably 82% or more, more preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 79% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0082] Examples of lipases composed of an amino acid sequence having at least 85% identity to the amino acid sequence shown in SEQ ID NO: 36 include lipases composed of an amino acid sequence having at least 85% identity to the amino acid sequence shown in SEQ ID NO: 36, specifically 85% or more, preferably 90% or more, more preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 85% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0083] Examples of lipases composed of an amino acid sequence having at least 73% identity to the amino acid sequence shown in SEQ ID NO: 38 include lipases composed of an amino acid sequence having at least 73% identity to the amino acid sequence shown in SEQ ID NO: 38, specifically 73% or more, preferably 75% or more, more preferably 80% or more, further preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 73% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0084] Examples of lipases composed of an amino acid sequence having at least 71% identity to the amino acid sequence shown in SEQ ID NO: 40 include lipases composed of an amino acid sequence having at least 71% identity to the amino acid sequence shown in SEQ ID NO: 40, specifically 71% or more, preferably 75% or more, more preferably 80% or more, further preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more identity to the amino acid sequence shown in SEQ ID NO: 40. Amino acid sequences having at least 71% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0085] Examples of lipases composed of an amino acid sequence having at least 72% identity to the amino acid sequence shown in SEQ ID NO: 42 include lipases composed of an amino acid sequence having at least 72% identity to the amino acid sequence shown in SEQ ID NO: 42, specifically 72% or more, preferably 75% or more, more preferably 80% or more, further preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 72% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0086] Examples of lipases composed of an amino acid sequence having at least 70% identity with the amino acid sequence shown in SEQ ID NO: 44 include lipases composed of an amino acid sequence having at least 70% identity with the amino acid sequence shown in SEQ ID NO: 44, specifically 70% or more, preferably 75% or more, more preferably 80% or more, further preferably 85% or more, further preferably 90% or more, further preferably 95% or more, further preferably 96% or more, further preferably 97% or more, further preferably 98% or more, further preferably 99% or more. Amino acid sequences having at least 70% identity include amino acid sequences in which one or more amino acids are deleted, inserted, substituted, or added.

[0087] Examples of “amino acid sequences after deletion, insertion, substitution or addition of one or more amino acids” include amino acid sequences after deletion, insertion, substitution or addition of 1 to 30 amino acids, preferably 20 to 20, more preferably 10 to 10, and even more preferably 5 to 5 amino acids.

[0088] An amino acid sequence having at least 79% identity with the amino acid sequence set forth in SEQ ID NO: 14, an amino acid sequence having at least 76% identity with the amino acid sequence set forth in SEQ ID NO: 16, an amino acid sequence having at least 81% identity with the amino acid sequence set forth in SEQ ID NO: 18, an amino acid sequence having at least 83% identity with the amino acid sequence set forth in SEQ ID NO: 20, an amino acid sequence having at least 96% identity with the amino acid sequence set forth in SEQ ID NO: 22, an amino acid sequence having at least 83% identity with the amino acid sequence set forth in SEQ ID NO: 24, an amino acid sequence having at least 90% identity with the amino acid sequence set forth in SEQ ID NO: 26, an amino acid sequence having at least 82% identity with the amino acid sequence set forth in SEQ ID NO: 28, an amino acid sequence having at least 73% identity with the amino acid sequence set forth in SEQ ID NO: 30, an amino acid sequence having at least 73% identity with the amino acid sequence set forth in SEQ ID NO: 32 The lipase consisting of an amino acid sequence having at least 73% identity with the amino acid sequence, an amino acid sequence having at least 79% identity with the amino acid sequence shown in SEQ ID NO: 34, an amino acid sequence having at least 85% identity with the amino acid sequence shown in SEQ ID NO: 36, an amino acid sequence having at least 73% identity with the amino acid sequence shown in SEQ ID NO: 38, an amino acid sequence having at least 71% identity with the amino acid sequence shown in SEQ ID NO: 40, an amino acid sequence having at least 72% identity with the amino acid sequence shown in SEQ ID NO: 42, or an amino acid sequence having at least 70% identity with the amino acid sequence shown in SEQ ID NO: 44 can include, for example, artificially produced mutants of lipases consisting of the amino acid sequences shown in SEQ ID NOs: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44. The mutant can be prepared by, for example, introducing a mutation into a gene encoding an amino acid sequence shown in sequence number 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44 using a known mutation introduction method such as ultraviolet irradiation or site-directed mutagenesis, expressing the gene having the mutation, and selecting a protein having the desired lipase activity. The steps for preparing such a mutant are well known to those skilled in the art.

[0089] The lipase of the present invention has an amino acid sequence different from the lipase separated or purified in the past and the protein presumed to be a triacylglycerol lipase in the NCBI protein sequence database. As the lipase separated or purified in the past, for example, the lipase TLL (sequence number 48) from Thermomyces lanuginosus, the lipase Lipr139 (sequence number 2) from Cedecea sp.-16640 strain disclosed in the above-mentioned patent document 1 as a lipase suitable for cleaning, the lipase from Proteus bacteria disclosed as the parent enzyme of the lipase mutant group suitable for cleaning in the above-mentioned patent document 2 (hereinafter referred to as PvLip, sequence number 4), the lipase Lipr138 (sequence number 46) from the metagenome disclosed in the above-mentioned patent document 3 as a lipase suitable for cleaning, etc. can be cited. In addition, proteins inferred to be triacylglycerol lipases in the NCBI protein sequence database include: a protein with accession number WP_123598507.1 (hereinafter referred to as PfLip, sequence number 6), a protein with accession number WP_115457195.1 (hereinafter referred to as EtLip, sequence number 8), a protein with accession number WP_135495634.1 (hereinafter referred to as EspLip, sequence number 10), a protein with accession number WP_005161363.1 (hereinafter referred to as YeLip, sequence number 12), etc. The enzymatic properties of these proteins registered in the database have not been reported so far.

[0090] The lipase encoded by the amino acid sequence shown in SEQ ID NO: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44 is respectively referred to as AncLip1, AncLip2, AncLip3, AncLip4, AncLip5, AncLip6, AncLip7, AncLip8, AncLip9, AncLip10, AncLip11, AncLip12, AncLip13, AncLip14, AncLip15, AncLip16.

[0091] AncLip1 shows 78% amino acid sequence identity with a lipase from Pseudomonas sp. registered in the NCBI protein sequence database as accession number WP_131062716.1. AncLip2 shows 75% amino acid sequence identity with a lipase from Proteusterrae registered in the NCBI protein sequence database as accession number WP_109394219.1. AncLip3 shows 80% amino acid sequence identity with a lipase from Enterobacillus tribolii registered in the NCBI protein sequence database as accession number WP_115457195.1. AncLip4 ​​shows 82% amino acid sequence identity with a lipase from Serratia registered in the NCBI protein sequence database as accession number WP_025122441.1. AncLip5 shows 95% amino acid sequence identity with a lipase from Yersinia aleksiciae registered in the NCBI protein sequence database as accession number WP_050126899.1. AncLip6 shows 82% amino acid sequence identity with a lipase from Escherichia coli registered in the NCBI protein sequence database as accession number WP_045783583.1. AncLip7 shows 89% amino acid sequence identity with a lipase from Chania multitudinisentens registered in the NCBI protein sequence database as accession number WP_037407093.1. AncLip8 shows 81% amino acid sequence identity with a lipase from Serratia marcescens registered in the NCBI protein sequence database as accession number WP_033635162.1. AncLip9 shows 72% amino acid sequence identity with a lipase from Snodgrassella alvi logged in the NCBI protein sequence database as accession number WP_100141403.1. AncLip10 shows 72% amino acid sequence identity with a lipase from Yersinia nurmii logged in the NCBI protein sequence database as accession number WP_049600386.1. AncLip11 shows 78% amino acid sequence identity with a lipase from Yersinianurmii logged in the NCBI protein sequence database as accession number WP_049600386.1.AncLip12 shows 84% ​​amino acid sequence identity with a lipase from Yersinia enterocolitica logged in the NCBI protein sequence database as accession number WP_057631122.1. AncLip13 shows 72% amino acid sequence identity with a lipase from Snodgrassella logged in the NCBI protein sequence database as accession number WP_025329791.1. AncLip14 shows 70% amino acid sequence identity with a lipase from Serratia marcescens logged in the NCBI protein sequence database as accession number WP_033635162.1. AncLip15 shows 71% amino acid sequence identity with a lipase from Snodgrassella logged in the NCBI protein sequence database as accession number WP_025329791.1. AncLip16 shows 69% amino acid sequence identity with a lipase from Pseudomonas lundensis registered in the NCBI protein sequence database as accession number WP_097192271.1.

[0092] In a preferred embodiment, the lipase of the present invention is a lipase consisting of the amino acid sequence shown in sequence numbers 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44, more preferably a lipase consisting of the amino acid sequence shown in sequence numbers 14, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 or 42.

[0093] <2. Method for producing lipase>

[0094] The lipase of the present invention can be produced, for example, by expressing a polynucleotide encoding the lipase of the present invention. Preferably, the lipase of the present invention can be produced by a transformant into which a polynucleotide encoding the lipase of the present invention has been introduced. For example, if a polynucleotide encoding the lipase of the present invention or a vector comprising the polynucleotide is introduced into a host, and a transformant is obtained, and the transformant is cultured with a suitable culture medium, the lipase of the present invention can be produced by the polynucleotide encoding the lipase of the present invention introduced into the transformant. The lipase of the present invention can be obtained by isolating or purifying the produced lipase from the culture.

[0095] The polynucleotide encoding the lipase of the present invention may be an amino acid sequence as shown in sequence number 14 or an amino acid sequence having at least 79% identity thereto, an amino acid sequence as shown in sequence number 16 or an amino acid sequence having at least 76% identity thereto, an amino acid sequence as shown in sequence number 18 or an amino acid sequence having at least 81% identity thereto, an amino acid sequence as shown in sequence number 20 or an amino acid sequence having at least 83% identity thereto, an amino acid sequence as shown in sequence number 22 or an amino acid sequence having at least 96% identity thereto, an amino acid sequence as shown in sequence number 24 or an amino acid sequence having at least 83% identity thereto, an amino acid sequence as shown in sequence number 26 or an amino acid sequence having at least 90% identity thereto, an amino acid sequence as shown in sequence number 28 or an amino acid sequence having at least 82% identity thereto. The invention also provides a polynucleotide encoding a lipase having an amino acid sequence of at least 73% of the amino acid sequence, an amino acid sequence of at least 73% of the amino acid sequence of SEQ ID NO: 30, an amino acid sequence having at least 73% identity thereto, an amino acid sequence of at least 73% of the amino acid sequence of SEQ ID NO: 32, an amino acid sequence of at least 79% of the amino acid sequence of SEQ ID NO: 34, an amino acid sequence of at least 79% of the amino acid sequence of SEQ ID NO: 36, an amino acid sequence of at least 85% of the amino acid sequence of SEQ ID NO: 38, an amino acid sequence of at least 73% of the amino acid sequence of SEQ ID NO: 40, an amino acid sequence of at least 71% of the amino acid sequence of SEQ ID NO: 42, an amino acid sequence of at least 72% of the amino acid sequence of SEQ ID NO: 44, or an amino acid sequence of at least 70% of the amino acid sequence of SEQ ID NO: 44. In addition, the polynucleotide encoding the lipase of the present invention may be in the form of single-stranded or double-stranded DNA, RNA, or artificial nucleic acid, or may be cDNA, or chemically synthesized DNA without introns.

[0096] The polynucleotide encoding the lipase of the present invention can be synthesized chemically or by genetic engineering based on the amino acid sequence of the lipase. For example, the polynucleotide can be chemically synthesized based on the amino acid sequence of the lipase of the present invention described above. The chemical synthesis of polynucleotides can utilize a nucleic acid synthesis trust service (for example, provided by the Institute of Medical Biology, Co., Ltd., Genscript, etc.). In addition, the synthesized polynucleotide can also be amplified by PCR, cloning, etc.

[0097] Alternatively, the polynucleotide encoding the lipase of the present invention can be prepared by introducing mutations into the polynucleotide synthesized by the above-mentioned steps using a known mutation introduction method such as the above-mentioned ultraviolet irradiation or site-directed mutagenesis. For example, the polynucleotide encoding the lipase of the present invention can be obtained by introducing mutations into the polynucleotide of sequence number 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41 or 43 using a known method, expressing the obtained polynucleotide, investigating the lipase activity, and selecting a polynucleotide encoding a protein having the desired lipase activity.

[0098] Site-directed mutagenesis in polynucleotides can be introduced by any method such as inverse PCR or annealing method (Muramatsu et al., "New Gene Engineering Handbook, Revised 4th Edition", Yangtusha, p. 82-88). Various commercially available kits for site-directed mutagenesis introduction such as Stratagene's QuickChange II Site-Directed Mutagenesis Kit or QuickChange Multi Site-Directed Mutagenesis Kit can also be used as needed.

[0099] The polynucleotide encoding the lipase of the present invention can be integrated into a vector. The type of the vector containing the polynucleotide is not particularly limited, and can be any vector of a plasmid, a phage, a phagemid, a clay, a virus, a YAC vector, a shuttle vector, etc. In addition, the vector is not limited, and is preferably a vector that can be amplified in bacteria, preferably in a bacillus bacterium (e.g., Bacillus subtilis or its mutant strain), and more preferably an expression vector that can induce the expression of the introduced gene in a bacillus bacterium. Among them, a shuttle vector that can replicate in bacillus bacteria and other organisms can be suitably used in the recombinant production of the lipase of the present invention. Examples of preferred vectors include, but are not limited to, shuttle vectors such as pHA3040SP64, pHSP64R or pASP64 (Japanese Patent No. 3492935), pHY300PLK (an expression vector capable of transforming both Escherichia coli and Bacillus subtilis; Jpn J Genet, 1985, 60: 235-243), and pAC3 (Nucleic Acids Res, 1988, 16: 8732); plasmid vectors that can be used for transformation of Bacillus bacteria such as pUB110 (J Bacteriol, 1978, 134: 318-329) and pTA10607 (Plasmid, 1987, 18: 8-15). Alternatively, a plasmid vector derived from Escherichia coli (e.g., pET22b(+), pBR322, pBR325, pUC57, pUC118, pUC119, pUC18, pUC19, pBluescript, etc.) can also be used.

[0100] The above-mentioned vector may contain a DNA replication initiation region or a DNA region containing a replication origin. Alternatively, in the above-mentioned vector, a promoter region, a terminator region, or a control sequence such as a secretion signal region for secreting the expressed protein into the cell, which is used to start transcription of the gene, may be operably connected upstream of the polynucleotide encoding the lipase of the present invention (i.e., the lipase gene of the present invention). In this specification, "operably connected" between a gene and a control sequence means that the gene and the control region are configured in a manner such that the gene can be expressed under the control of the control region.

[0101] The types of control sequences such as the above-mentioned promoter region, terminator region, secretion signal region, etc. are not particularly limited, and can be appropriately selected from commonly used promoters or secretion signal sequences according to the host to be introduced. For example, as preferred examples of control sequences that can be integrated into the vector, the promoter and secretion signal sequence of the cellulase gene of Baclus sp. KSM-S237 strain can be cited.

[0102] Alternatively, the vector of the present invention may further be integrated with a marker gene (e.g., a resistance gene for drugs such as ampicillin, neomycin, kanamycin, chloramphenicol, etc.) for selecting a host into which the vector is appropriately introduced. Alternatively, when a host uses an auxotrophic strain, a gene encoding a synthase of the desired nutrition may be integrated into the vector as a marker gene. Alternatively, when a selective culture medium requiring a specific metabolism for growth is used, a gene related to the metabolism may be integrated into the vector as a marker gene. As an example of such a metabolism-related gene, an acetamidoase gene for utilizing acetamide as a nitrogen source may be cited.

[0103] The polynucleotide encoding the lipase of the present invention can be linked to the control sequence and the marker gene by methods known in the art such as SOE (splicing by overlap extension)-PCR (Gene, 1989, 77: 61-68). The step of introducing the linked fragments into the vector is known in the art.

[0104] The transformed cell of the present invention can be obtained by introducing a vector comprising a polynucleotide encoding the lipase of the present invention into a host, or by introducing a DNA fragment comprising a polynucleotide encoding the lipase of the present invention into the genome of a host.

[0105] As host cells, microorganisms such as bacteria and filamentous fungi can be cited. Examples of bacteria include bacteria belonging to Escherichia coli, Staphylococcus, Enterococcus, Listeria, and Bacillus, among which Escherichia coli and Bacillus bacteria (e.g., Bacillus subtilis Marburg No. 168 or its mutant) are preferred. Examples of Bacillus subtilis mutants include the protease 9-fold defective strain KA8AX described in J. Biosci. Bioeng., 2007, 104 (2): 135-143, and the D8PA strain that improves the protein folding efficiency of the protease 8-fold defective strain described in Biotechnol. Lett., 2011, 33 (9): 1847-1852. Examples of filamentous fungi include Trichoderma, Aspergillus, and Rhizopus.

[0106] As a method for introducing a vector into a host, a method commonly used in the art such as a protoplast method and an electroporation method can be used. By selecting a strain into which the vector has been appropriately introduced based on the expression of a marker gene, auxotrophy, etc., a target transformant into which the vector has been introduced can be obtained.

[0107] Alternatively, the fragment formed by connecting the polynucleotide encoding the lipase of the present invention, the control sequence and the marker gene can also be directly introduced into the host's genome. For example, by the SOE-PCR method, a DNA fragment with a sequence complementary to the host's genome added to both ends of the above-mentioned connecting fragment is constructed, and the DNA fragment is introduced into the host, so that homologous recombination occurs between the host genome and the DNA fragment, thereby importing the polynucleotide encoding the lipase of the present invention into the host's genome.

[0108] If the transformant thus obtained into which the polynucleotide encoding the lipase of the present invention or a vector containing the polynucleotide is introduced is cultured with an appropriate medium, the gene encoding the protein on the vector is expressed to produce the lipase of the present invention. The medium used in the culture of the transformant can be appropriately selected by those skilled in the art according to the type of the microorganism of the transformant.

[0109] Alternatively, the lipase of the present invention can also be expressed from a polynucleotide encoding the lipase of the present invention or its transcript using a cell-free translation system. A "cell-free translation system" is an in vitro transcription-translation system or an in vitro translation system formed by adding reagents such as amino acids necessary for protein translation to a suspension obtained by mechanically disrupting cells as a host.

[0110] The lipase of the present invention produced by the above-mentioned culture or cell-free translation system can be isolated or purified by using the usual methods used for protein purification, such as centrifugation, ammonium sulfate precipitation, gel chromatography, ion exchange chromatography, affinity chromatography, etc., alone or in appropriate combination. The protein recovered from the culture can also be further purified by a known method.

[0111] <3. Cleaning agent composition>

[0112] The lipase of the present invention thus obtained has significantly higher resistance to lipase activity inhibition by surfactants than known proteins, and exhibits significantly higher detergency even in the presence of surfactants.

[0113] Here, "high tolerance" refers to a higher tolerance than a known protein, specifically a lipase consisting of an amino acid sequence shown in sequence number 2, 4, 6, 8, 10 or 12, or a protein inferred to be a lipase in the NCBI protein sequence database. The tolerance to the inhibition of lipase activity caused by a surfactant can be evaluated using a method known in the art. For example, a lipase solution is mixed with a surfactant solution, a 4-nitrophenyl octanoate solution as a substrate for lipase is added to the mixed solution, and the absorbance change (OD / min) at 405nm with the free 4-nitrophenol is measured, and the difference ΔOD / min with the blank is obtained as the lipase activity value (lipase activity value in the surfactant solution). In addition, the lipase activity value (lipase activity value in the buffer) when a buffer solution is used instead of a surfactant solution is obtained, and the lipase activity value in the surfactant solution is divided by the lipase activity value in the buffer solution, and then multiplied by 100 to obtain the value as the relative activity (%). The higher the relative activity (%), the higher the tolerance to the inhibition of lipase activity caused by the surfactant can be judged.

[0114] The lipase of the present invention is a lipase having a relative lipase activity (%) in a Triton X-100 solution (0.1% (w / v)) of preferably 20% or more, more preferably 30% or more, and even more preferably 50% or more under the conditions of Example (3) described below.

[0115] In addition, "high cleaning power" refers to a higher cleaning power than a known protein, specifically a lipase consisting of an amino acid sequence shown in sequence number 2, 4, 6, 8, 10 or 12 or a protein inferred to be a lipase in the NCBI protein sequence database, such as the ability to remove dirt in a washing or cleaning process. Cleaning power can be evaluated using methods known in the art. For example, a cleaning solution containing a lipase is added to a model dirt containing a specified indicator substance (such as a dye with high solubility in fat, such as Sudan III) and cleaned under specified conditions. A portion of the cleaning solution can be separated, such as by measuring the concentration of the indicator substance in the model dirt that is soluble in the cleaning solution by cleaning, and the difference with the blank is obtained as the cleaning power.

[0116] The lipase of the present invention is useful as an enzyme to be incorporated into various detergent compositions, and is particularly useful as an enzyme to be incorporated into detergent compositions suitable for low-temperature cleaning.

[0117] Here, "low temperature" includes 40°C or less, 35°C or less, 30°C or less, and 25°C or less, and 5°C or more, 10°C or more, and 15°C or more. Also, 5-40°C, 10-35°C, 15-30°C, and 15-25°C can be mentioned.

[0118] The amount of the lipase of the present invention in the detergent composition is not particularly limited as long as it is an amount in which the lipase exhibits activity, for example, preferably 0.1 mg or more, more preferably 1 mg or more, more preferably 5 mg or more, and preferably 5000 mg or less, more preferably 1000 mg or less, more preferably 500 mg or less per 1 kg of the detergent composition. In addition, it is preferably 0.1 to 5000 mg, more preferably 1 to 1000 mg, and more preferably 5 to 500 mg.

[0119] The detergent composition preferably includes sulfosuccinate or its salt in addition to the lipase of the present invention.Sulfosuccinate or its salt is known to be a component (e.g., Japanese Patent Publication No. 2019-182911) formulated in a detergent composition.Sulfosuccinate or its salt is preferably a sulfosuccinic acid branched alkyl ester or its salt with a branched alkyl group having more than 9 carbon atoms and less than 12 carbon atoms, more preferably a sulfosuccinic acid branched alkyl ester or its salt with a branched alkyl group having 9 or 10 carbon atoms, and further preferably a sulfosuccinic acid branched alkyl ester or its salt with a branched alkyl group having 10 carbon atoms. In addition, the sulfosuccinate or its salt is preferably a di-branched alkyl sulfosuccinate or its salt, and the two branched alkyl groups are respectively a branched alkyl group having 9 to 12 carbon atoms, or a salt thereof, more preferably a di-branched alkyl sulfosuccinate or its salt in which the two branched alkyl groups are respectively a branched alkyl group having 9 or 10 carbon atoms, further preferably a di-branched alkyl sulfosuccinate or its salt in which the two branched alkyl groups are respectively a branched alkyl group having 10 carbon atoms, and further preferably bis-(2-propylheptyl) sulfosuccinate or its salt.

[0120] Examples of the salt include alkali metal salts and alkanolamine salts, preferably alkali metal salts or alkanolamine salts, more preferably salts selected from sodium salts, potassium salts, triethanolamine salts, diethanolamine salts, and monoethanolamine salts, and still more preferably sodium salts.

[0121] Examples of the sulfosuccinate or its salt include compounds represented by the following formula 1.

[0122]

[0123] [In Formula 1, R 1 , R 2 are branched alkyl groups having 9 to 12 carbon atoms, A 1 O.A 2 O is an alkyleneoxy group having 2 to 4 carbon atoms, x1 and x2 are average addition mole numbers, which are 0 to 10, respectively, and M is a cation.

[0124] In formula 1, R 1 , R2 Preferably, they are branched alkyl groups selected from branched nonyl, branched decyl and branched dodecyl, and more preferably branched decyl. The branched decyl group is preferably 2-propylheptyl.

[0125] In formula 1, A 1 O.A 2 O each has 2 or more carbon atoms and 4 or less carbon atoms, and is preferably an alkyleneoxy group having 2 or 3 carbon atoms from the viewpoint of lubricity to water. 1 O.A 2 The average added molar number of O is 0 to 10, and is preferably 6 to 6, more preferably 4 to 4, further preferably 2 to 2, and further preferably 0, from the viewpoint of lubricity to water.

[0126] In Formula 1, M is a cation. M is preferably a cation other than a hydrogen ion. Examples of M include alkali metal ions such as lithium ions, sodium ions, and potassium ions, alkaline earth metal ions such as calcium ions and barium ions, and organic ammonium ions such as triethanolammonium ions, diethanolammonium ions, monoethanolammonium ions, trimethylammonium ions, and monomethylammonium ions.

[0127] From the viewpoint of dispersibility in water, M is preferably an alkali metal ion or an alkanolammonium ion, more preferably a sodium ion, a potassium ion, a triethanolammonium ion, a diethanolammonium ion, or a monoethanolammonium ion, and still more preferably a sodium ion.

[0128] The sulfosuccinate or its salt is preferably a compound represented by the following formula 1-1: The compound of formula 1-1 is a compound wherein x1 and x2 in formula 1 are each 0.

[0129]

[0130] [In Formula 1-1, R 1 , R 2 They are branched alkyl groups with 9 to 12 carbon atoms, and M is a cation.

[0131] R in Formula 1-1 1 , R 2 Specific examples or preferred examples of M are the same as those in Formula 1.

[0132] In a preferred embodiment, the sulfosuccinate or its salt is bis(2-propylheptyl)sulfosuccinate or its salt.

[0133] The amount of the sulfosuccinate or its salt in the detergent composition is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and preferably 2.0% by mass or less, more preferably 1.0% by mass or less. It is preferably 0.01 to 2.0% by mass, and more preferably 0.1 to 1.0% by mass.

[0134] The detergent composition may also use various enzymes in addition to the lipase of the present invention. For example, hydrolases, oxidases, reductases, transferases, lyases, isomerases, ligases, synthetases, etc. Among them, lipases, amylases, proteases, cellulases, keratinases, esterases, cutinases, pullulanases, pectinases, mannanases, glucosidases, dextranases, cholesterol oxidases, peroxidases, laccases, etc., which are different from the lipase of the present invention, are preferred, and proteases, cellulases, amylases, and lipases are particularly preferred.

[0135] Examples of the protease include commercially available Alcalase, Esperase, Everlase, Savinase, Kannase, Progress Uno (registered trademark; Novozymes A / S), PREFERENZ, EFFECTENZ, EXCELLENZ (registered trademark; DuPont), Lavergy (registered trademark; BASF), and KAP (Kao).

[0136] Examples of the cellulase include Celluclean, Carezyme (registered trademark; Novozymes A / S), and KAC, alkaline cellulase produced by Bacillus sp. KSM-S237 strain described in Japanese Patent Application Laid-Open No. 10-313859, and mutant alkaline cellulase described in Japanese Patent Application Laid-Open No. 2003-313592 (all from Kao).

[0137] Examples of the amylase include Termamyl, Duramyl, Stainzyme, Stainzyme Plus, AmplifyPrime (registered trademark; Novozymes A / S), PREFERENZ, EFFECTENZ (registered trademark; DuPont), and KAM (Kao).

[0138] Examples of the lipase include Lipolase and Lipex (registered trademark; Novozymes A / S).

[0139] The detergent composition can contain a known detergent component, and examples of the known detergent component include the following.

[0140] (1) Surfactants

[0141] The surfactant is used in the detergent composition in an amount of 0.5 to 60% by mass, preferably 10 to 45% by mass in a powdered detergent composition, and preferably 20 to 90% by mass in a liquid detergent composition. In addition, when the detergent composition of the present invention is a laundry detergent or an automatic dishwashing machine detergent, the surfactant is usually used in an amount of 1 to 10% by mass, preferably 1 to 5% by mass.

[0142] Examples of the surfactant used in the detergent composition include anionic surfactants, nonionic surfactants, amphoteric surfactants, and cationic surfactants, or a combination thereof, except for the above-mentioned sulfosuccinates or salts thereof, and anionic surfactants and nonionic surfactants are preferred.

[0143] As anionic surfactants, preferred are sulfates of alcohols having 10 to 18 carbon atoms, sulfates of alkoxylates of alcohols having 8 to 20 carbon atoms, alkylbenzene sulfonates, paraffin sulfonates, α-olefin sulfonates, internal olefin sulfonates, α-sulfo fatty acid salts, α-sulfo fatty acid alkyl ester salts or fatty acid salts. In the present invention, it is particularly preferred to select one or more anionic surfactants from linear alkylbenzene sulfonates having 10 to 14 carbon atoms, more preferably 12 to 14 carbon atoms in the alkyl chain, and internal olefin sulfones having 12 to 20 carbon atoms, more preferably 16 to 18 carbon atoms in the alkylene chain. As counterions, alkali metal salts or amines are preferred, and sodium and / or potassium, monoethanolamine, and diethanolamine are particularly preferred. Internal olefin sulfonic acid can refer to, for example, WO2017 / 098637.

[0144] As the nonionic surfactant, polyoxyalkylene alkyl (carbon number 8-20) ether, alkyl polyglycoside, polyoxyalkylene alkyl (carbon number 8-20) phenyl ether, polyoxyalkylene sorbitan fatty acid (carbon number 8-22) ester, polyoxyalkylene glycol fatty acid (carbon number 8-22) ester, polyoxyethylene polyoxypropylene block polymer are preferred. In particular, polyoxyalkylene alkyl ethers (such as HLB value (calculated by Griffin method) having 4 to 20 mol of alkylene oxide such as ethylene oxide or propylene oxide added to alcohol having 10 to 18 carbon atoms are preferred.

[0145] (2) Divalent Metal Ion Scavenger

[0146] The divalent metal ion scavenger is added in an amount of 0.01 to 50% by mass, preferably 5 to 40% by mass. Examples of the divalent metal ion scavenger used in the detergent composition of the present invention include: condensed phosphates such as tripolyphosphates, pyrophosphates, orthophosphates, aluminosilicates such as zeolites, synthetic layered crystalline silicates, nitrilotriacetates, ethylenediaminetetraacetates, citrates, isocitrates, polyacetal carboxylates, and the like. Among them, crystalline aluminosilicates (synthetic zeolites) are particularly preferred, and among type A, type X, and type P zeolites, type A is particularly preferred. Synthetic zeolites are preferably zeolites having an average primary particle size of 0.1 to 10 μm, particularly 0.1 to 5 μm.

[0147] (3) Alkali

[0148] The alkali agent is mixed in an amount of 0.01 to 80% by mass, preferably 1 to 40% by mass. In the case of powder detergents, alkali metal carbonates such as sodium carbonate, which are collectively referred to as heavy ash and light ash, and amorphous alkali metal silicates such as JIS No. 1, No. 2, and No. 3 can be cited. These inorganic alkali agents are effective in forming the skeleton of the particles when the detergent is dried, and a relatively hard detergent with excellent fluidity can be obtained. As alkalis other than these, sodium sesquicarbonate, sodium bicarbonate, etc. can be cited. In addition, phosphates such as tripolyphosphate also have the effect of acting as alkali agents. In addition, as alkali agents used in liquid detergents, in addition to the above-mentioned alkali agents, sodium hydroxide, as well as monoethanolamine, diethanolamine or triethanolamine can also be used, and can also be used as the counter ion of the activator.

[0149] (4) Anti-recontamination agent

[0150] The re-contamination prevention agent is mixed at 0.001 to 10% by mass, preferably 1 to 5% by mass. Examples of the re-contamination prevention agent used in the detergent composition of the present invention include polyethylene glycol, carboxylic acid polymers, polyvinyl alcohol, polyvinyl pyrrolidone, etc. Among them, in addition to the ability to prevent re-contamination, the carboxylic acid polymer also has the function of capturing metal ions and dispersing solid particle dirt from clothes into the washing bath. The carboxylic acid polymer is a homopolymer or copolymer of acrylic acid, methacrylic acid, itaconic acid, etc. As a copolymer, a copolymer formed by copolymerization of the above monomers with maleic acid is preferred, and the molecular weight is preferably several thousand to 100,000. In addition to the above-mentioned carboxylic acid polymers, polymers such as polyglycidyl salts, cellulose derivatives such as carboxymethyl cellulose, and aminocarboxylic acid polymers such as polyaspartic acid are also preferred because they have metal ion capture agents, dispersants and re-contamination prevention capabilities.

[0151] (5) Bleach

[0152] For example, bleaching agents such as hydrogen peroxide and percarbonate are preferably blended in an amount of 1 to 10% by mass. When a bleaching agent is used, a bleaching activator (activator) such as tetraacetylethylenediamine (TAED) or one described in Japanese Patent Application Laid-Open No. 6-316700 may be blended in an amount of 0.01 to 10% by mass.

[0153] (6) Fluorescent agent

[0154] Examples of the fluorescent agent used in the cleaning composition include biphenyl fluorescent agents (eg, Tinopal CBS-X) and stilbene fluorescent agents (eg, DM fluorescent dyes). The fluorescent agent is preferably blended in an amount of 0.001 to 2% by mass.

[0155] (7) Other ingredients

[0156] The detergent composition may contain a builder, softener, reducing agent (sulfite, etc.), foam suppressor (silicone, etc.), fragrance, antibacterial and antifungal agent (Proxel [trade name], benzoic acid, etc.), and other additives known in the field of laundry detergents.

[0157] The detergent composition can be prepared by combining the lipase of the present invention obtained by the above method with the above known detergent components in a conventional manner. The form of the detergent can be selected according to the application, and can be, for example, liquid, powder, granule, paste, solid, etc.

[0158] The detergent composition thus obtained can be used as a laundry detergent, a dishwashing detergent, a bleaching agent, a detergent for cleaning hard surfaces, a drain cleaner, a denture cleaner, a disinfectant for medical instruments, and the like. Preferred examples include laundry detergents and dishwashing detergents, and more preferred examples include laundry detergents (laundry detergents), hand-washed dishwashing detergents, and detergents for automatic dishwashing machines.

[0159] The detergent composition is suitable for use at 40°C or less, 35°C or less, 30°C or less, 25°C or less, and 5°C or more, 10°C or more, or 15°C or more. It is also suitable for use at 5-40°C, 10-35°C, 15-30°C, or 15-25°C. Preferred usages include use in low-temperature (15-30°C) cleaning in a laundry and use in low-temperature (15-30°C) cleaning using an automatic dishwasher.

[0160] By using the cleaning composition of the present invention, it is possible to clean the object to be cleaned (e.g., clothes, tableware, hard surfaces, drain pipes, dentures, medical instruments, etc.) from which dirt needs to be removed, i.e., remove dirt. The cleaning method comprises the step of contacting the object to be cleaned from which dirt needs to be removed with the cleaning composition of the present invention. Preferably, the dirt is sebum dirt or dirt containing oil from food.

[0161] In the cleaning method of the present invention, the object to be cleaned may be brought into contact with the detergent composition by immersing the object to be cleaned in water in which the detergent composition is dissolved, or by directly applying the detergent composition to the object to be cleaned. In the method of the present invention, the object to be cleaned after immersion or application of the detergent composition may be further washed by hand or by washing with a washing machine, but this is not essential.

[0162] Regarding the above-mentioned embodiment, the present invention further discloses the following aspects.

[0163] <1> Any of the following lipases:

[0164] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 14 or an amino acid sequence having at least 79% identity thereto;

[0165] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 16 or an amino acid sequence having at least 76% identity thereto;

[0166] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 81% identity thereto;

[0167] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 20 or an amino acid sequence having at least 83% identity thereto;

[0168] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 22 or an amino acid sequence having at least 96% identity thereto;

[0169] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 83% identity thereto;

[0170] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 26 or an amino acid sequence having at least 90% identity thereto;

[0171] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 28 or an amino acid sequence having at least 82% identity thereto;

[0172] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 30 or an amino acid sequence having at least 73% identity thereto;

[0173] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 32 or an amino acid sequence having at least 73% identity thereto;

[0174] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 34 or an amino acid sequence having at least 79% identity thereto;

[0175] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 36 or an amino acid sequence having at least 85% identity thereto;

[0176] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 38 or an amino acid sequence having at least 73% identity thereto;

[0177] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 40 or an amino acid sequence having at least 71% identity thereto;

[0178] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 42 or an amino acid sequence having at least 72% identity thereto; and

[0179] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 44 or an amino acid sequence having at least 70% identity thereto.

[0180] <2> The lipase according to <1>, which consists of the amino acid sequence shown in SEQ ID NO: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

[0181] <3> A polynucleotide encoding the lipase described in <1> or <2>.

[0182] <4> A vector or a DNA fragment comprising the polynucleotide described in <3>.

[0183] <5> A transformed cell comprising the vector or DNA fragment described in <4>.

[0184] <6> The transformed cell according to <5>, wherein the transformed cell is a microorganism.

[0185] <7> The transformed cell according to <5> or <6>, wherein the transformed cell is Escherichia coli or a bacterium of the genus Bacillus.

[0186] <8> A cleaning composition comprising the lipase according to <1> or <2>.

[0187] <9> The cleaning composition as described in <8>, which further contains a sulfosuccinate or a salt thereof, preferably a branched alkyl sulfosuccinate having a branched alkyl group having 9 to 12 carbon atoms or a salt thereof, more preferably a branched alkyl sulfosuccinate having a branched alkyl group having 9 or 10 carbon atoms or a salt thereof, and further preferably a branched alkyl sulfosuccinate having a branched alkyl group having 10 carbon atoms or a salt thereof.

[0188] <10> The cleaning composition as described in <8>, which further contains a sulfosuccinic acid diester or a salt thereof, preferably a sulfosuccinic acid dibranched alkyl ester or a salt thereof in which the two branched alkyl groups are each a branched alkyl group having 9 to 12 carbon atoms, more preferably a sulfosuccinic acid dibranched alkyl ester or a salt thereof in which the two branched alkyl groups are each a branched alkyl group having 9 or 10 carbon atoms, further preferably a sulfosuccinic acid dibranched alkyl ester or a salt thereof in which the two branched alkyl groups are each a branched alkyl group having 10 carbon atoms, and further preferably bis(2-propylheptyl)sulfosuccinate or a salt thereof.

[0189] <11> The detergent composition according to any one of <8> to <10>, wherein the detergent composition is a laundry detergent or a dishwashing detergent.

[0190] <12> The cleaning composition according to any one of <8> to <11>, wherein the cleaning composition is a powder or a liquid.

[0191] <13> The cleaning composition according to any one of <8> to <12>, which is used at a low temperature.

[0192] <14> The cleaning composition according to <13>, which is used at 40°C or less, 35°C or less, 30°C or less, 25°C or less and 5°C or more, 10°C or more, or 15°C or more, or at 5-40°C, 10-35°C, 15-30°C, or 15-25°C.

[0193] <15> A method for cleaning dirt, comprising using the cleaning composition according to any one of <8> to <14>.

[0194] <16> The method according to <15>, comprising the step of bringing an object to be cleaned into contact with the cleaning composition according to any one of <8> to <14>.

[0195] <17> The method according to <15> or <16>, wherein the dirt is sebum dirt or dirt containing food-derived fat.

[0196] <18> Use of any of the following lipases in the manufacture of a cleaning composition:

[0197] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 14 or an amino acid sequence having at least 79% identity thereto;

[0198] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 16 or an amino acid sequence having at least 76% identity thereto;

[0199] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 81% identity thereto;

[0200] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 20 or an amino acid sequence having at least 83% identity thereto;

[0201] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 22 or an amino acid sequence having at least 96% identity thereto;

[0202] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 83% identity thereto;

[0203] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 26 or an amino acid sequence having at least 90% identity thereto;

[0204] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 28 or an amino acid sequence having at least 82% identity thereto;

[0205] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 30 or an amino acid sequence having at least 73% identity thereto;

[0206] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 32 or an amino acid sequence having at least 73% identity thereto;

[0207] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 34 or an amino acid sequence having at least 79% identity thereto;

[0208] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 36 or an amino acid sequence having at least 85% identity thereto;

[0209] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 38 or an amino acid sequence having at least 73% identity thereto;

[0210] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 40 or an amino acid sequence having at least 71% identity thereto;

[0211] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 42 or an amino acid sequence having at least 72% identity thereto; and

[0212] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 44 or an amino acid sequence having at least 70% identity thereto.

[0213] <19> The use according to <18>, wherein the lipase is a lipase consisting of the amino acid sequence shown in SEQ ID NO: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

[0214] <20> The use according to <18> or <19>, wherein the detergent composition is a laundry detergent or a dishwashing detergent.

[0215] <21> The use according to any one of <18> to <20>, wherein the cleaning composition is a powder or a liquid.

[0216] <22> The use according to any one of <18> to <21>, wherein the cleaning composition is used at a low temperature.

[0217] <23> The use according to <22>, wherein the cleaning composition is used at 40°C or less, 35°C or less, 30°C or less, 25°C or less and 5°C or more, 10°C or more, or 15°C or more, or at 5-40°C, 10-35°C, 15-30°C, or 15-25°C.

[0218] <24> Use of any of the following lipases in cleaning dirt:

[0219] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 14 or an amino acid sequence having at least 79% identity thereto;

[0220] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 16 or an amino acid sequence having at least 76% identity thereto;

[0221] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 81% identity thereto;

[0222] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 20 or an amino acid sequence having at least 83% identity thereto;

[0223] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 22 or an amino acid sequence having at least 96% identity thereto;

[0224] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 83% identity thereto;

[0225] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 26 or an amino acid sequence having at least 90% identity thereto;

[0226] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 28 or an amino acid sequence having at least 82% identity thereto;

[0227] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 30 or an amino acid sequence having at least 73% identity thereto;

[0228] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 32 or an amino acid sequence having at least 73% identity thereto;

[0229] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 34 or an amino acid sequence having at least 79% identity thereto;

[0230] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 36 or an amino acid sequence having at least 85% identity thereto;

[0231] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 38 or an amino acid sequence having at least 73% identity thereto;

[0232] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 40 or an amino acid sequence having at least 71% identity thereto;

[0233] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 42 or an amino acid sequence having at least 72% identity thereto; and

[0234] A lipase consisting of the amino acid sequence shown in SEQ ID NO: 44 or an amino acid sequence having at least 70% identity thereto.

[0235] <25> The use according to <24>, wherein the lipase is a lipase consisting of the amino acid sequence shown in SEQ ID NO: 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.

[0236] <26> The use according to <24> or <25>, wherein the dirt is sebum dirt or dirt containing food-derived fats and oils.

[0237] <27> The use according to any one of <24> to <26>, wherein the cleaning is cleaning at a low temperature.

[0238] <28> The use as described in <27>, wherein the cleaning is cleaning at below 40°C, below 35°C, below 30°C, below 25°C and above 5°C, above 10°C, or above 15°C, or cleaning is cleaning at 5-40°C, 10-35°C, 15-30°C, or 15-25°C.

[0239] Example

[0240] Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not limited thereto.

[0241] (1) Construction of lipase expression plasmid

[0242] The lipase expression plasmid is constructed using the VHH expression plasmid of sequence number 26 containing the promoter from the spoVG gene of Bacillus subtilis described in WO2021 / 153129 as a template. Each lipase gene is transferred to the full-length ORF containing the VHH gene of the above-mentioned plasmid by In-Fusion reaction for construction. The lipase genes Lipr139, PvLip, PfLip, EtLip, EspLip, YeLip, AncLip1, AncLip2, AncLip3, AncLip4, AncLip5, AncLip6, AncLip7, AncLip8, AncLip9, AncLip10, AncLip11, AncLip12, AncLip synthesized from artificial genes 13, AncLip14, AncLip15, AncLip16, Lipr138 (polynucleotides encoding sequence numbers 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45, respectively), and sequence numbers 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 2 8, 30, 32, 34, 36, 38, 40, 42, 44 and 46 amino acid sequences), and construct plasmids pHY-Lipr139, pHY-PvLip, pHY-PfLip, pHY-EtLip, pHY-EspLip, pHY-YeLip, pHY-AncLip1, pHY-AncLip2, pHY-AncLip3, pHY-AncLip4, pHY-A ncLip5, pHY-AncLip6, pHY-AncLip7, pHY-AncLip8, pHY-AncLip9, pHY-AncLip10, pHY-AncLip11, pHY-AncLip12, pHY-AncLip13, pHY-AncLip14, pHY-AncLip15, pHY-AncLip16, and pHY-Lipr138. In addition, the amino acid sequence represented by any one of sequence numbers 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, and 44 is a novel lipase sequence possessed by an ancestral organism of the source bacteria of existing lipases belonging to the Proteus / Yersinia evolutionary branch.Through In-Fusion reaction, the artificially synthesized gene of the lipase TLL gene (polynucleotide of sequence number 47, amino acid sequence encoding sequence number 48) with the signal sequence from Bacillus subtilis amyE (polynucleotide of sequence number 49, amino acid sequence encoding sequence number 50) connected at the N-terminus was transferred to the full-length ORF of the Lipr139 gene of the plasmid pHY-Lipr139 to construct pHY-amyEsig-TLL.

[0243] (2) Preparation of lipase solution

[0244] The lipase expression plasmid was introduced into the Bacillus subtilis strain by the protoplast method, and the culture was cultured at 30°C for 2 days using 2×L-maltose medium (2% tryptone, 1% yeast extract, 1% NaCl, 7.5% maltose, 7.5ppm manganese sulfate pentahydrate, 0.04% calcium chloride dihydrate, 15ppm tetracycline; % is (w / v)%), and the culture supernatant containing lipase was recovered by centrifugation. The culture supernatant was replaced with a buffer solution of 10mM Tris-HCl+0.01% Triton-X100 (pH7.0) by dialysis, and the lipase concentration was quantified by the band intensity of SDS-PAGE.

[0245] (3) Activity determination in surfactant solution

[0246] 4-Nitrophenyl octanoate (SIGMA) is used as a substrate. The activity of the lipase can be determined by measuring the rate of increase in the absorbance of the free 4-nitrophenol caused by the action of the lipase. 20mM 4-nitrophenyl octanoate in 20mM Tris-HCl (pH7.0) is used as a substrate solution. A solution in which 0.1% (w / v) SDS or Triton X-100 is added to 20mM Tris-HCl (pH7.0) is used as a surfactant solution. 5μL of the lipase solution adjusted to 2ppm and 100μL of the surfactant solution are mixed in each well of a 96-well assay plate, 10μL of the substrate solution is added, and the absorbance change (OD / min) at 405nm is measured at 30°C. The difference ΔOD / min with the blank (sample without enzyme addition) is taken as the activity value. For each lipase, the relative activity (%) was calculated by dividing the activity value (activity in buffer) when 20 mM Tris-HCl (pH 7.0) was used instead of the surfactant solution by the activity value in the surfactant solution and multiplying the result by 100 ( Figure 1 ).

[0247] TLL, Patent Documents 1, 2 and 3 disclose that Lipr139, PvLip and Lipr138, which are adaptable to cleaning, and PfLip, EtLip, EspLip and YeLip, which are lipase sequences existing in nature, are significantly inhibited in the presence of SDS and Triton X-100. Compared with these, the novel ancestral lipases AncLip1, AncLip2, AncLip3, AncLip4, AncLip5, AncLip6, AncLip7, AncLip8, AncLip9, AncLip10, AncLip11, AncLip12, AncLip13, AncLip14, AncLip15 and AncLip16 show higher resistance to the activity inhibition caused by Triton X-100. In addition, AncLip3, AncLip4, AncLip6, AncLip8, AncLip9, AncLip12, and AncLip13 showed high resistance to activity inhibition by SDS.

[0248] (4) Activity determination in model cleaning fluid

[0249] 20 mM 4-nitrophenyl octanoate in 20 mM Tris-HCl (pH 7.0) was used as the substrate solution. As the model cleaning solution, the aqueous medium in Table 1 was used. 2 μL of the lipase solution adjusted to 4 ppm and 100 μL of the test solution (model cleaning solution or 20 mM Tris-HCl (pH 7.0)) were mixed in each well of a 96-well assay plate, 10 μL of the substrate solution was added, and the absorbance change (OD / min) at 405 nm was measured at 30°C. The difference ΔOD / min with the blank (sample without enzyme addition) was calculated. 10 μL of 20 mM Tris-HCl (pH 7.0) containing 31 to 500 μM 4-nitrophenol was mixed with 100 μL of each test solution, and the absorbance at 405 nm was measured to prepare a standard curve. From the standard curve of each test solution and the value of ΔOD / min, the free rate of 4-nitrophenol per minute (μM / min) was calculated as the activity value.

[0250] For each lipase, the relative activity (%) was calculated by dividing the activity value (activity in buffer) when 20 mM Tris-HCl (pH 7.0) was used as the test solution by the activity value when the model cleaning solution was used as the test solution and multiplying the result by 100 ( Figure 2 ).

[0251] TLL, Patent Documents 1, 2 and 3 disclose that Lipr139, PvLip and Lipr138, which are adaptable to cleaning, and PfLip, EtLip, EspLip and YeLip, which are lipase sequences existing in nature, are significantly inhibited in activity in a model cleaning solution. Compared with these, the novel ancestral lipases AncLip1, AncLip3, AncLip4, AncLip6, AncLip7, AncLip8, AncLip9, AncLip10, AncLip11, AncLip12, AncLip13, AncLip14, AncLip15 and AncLip16 show higher resistance to activity inhibition in a model cleaning solution.

[0252] [Table 1]

[0253] Compounding ingredients quality% Branched chain alkyl sulfosuccinate 0.2 Betaine 2 Diethylene glycol butyl ether 6.5 water margin total 100

[0254] Sulfosuccinic acid branched alkyl ester: sodium bis(2-propylheptyl)sulfosuccinate

[0255] Betaine: Lauryl (2-hydroxy-3-sulfopropyl) dimethyl betaine, AMPHITOL 20HD, manufactured by Kao Corporation

[0256] (5) Cleaning evaluation in model cleaning fluid

[0257] Beef tallow (SIGMA, 03-0660) and rapeseed oil (SIGMA, 23-0450) were mixed at a weight ratio of 9:1, dissolved in 3 times the amount of chloroform, and then stained with 0.2wt% Sudan III. The stained material was used as a model dirt. 10μL of each model dirt was dripped into the bottom of a 96-well deep-well plate made of polypropylene, and the chloroform was evaporated and dried to prepare a dirt plate.

[0258] Add 1 / 100 volume of 240 ppm lipase solution to the model cleaning solution listed in Table 1, and use the resulting mixture as the cleaning solution. Slowly add 300 μL of each cleaning solution to the dirt plate, and let it stand at room temperature (about 22°C) for 15 minutes for immersion cleaning. Take out 100 μL of each cleaning solution without touching the dirt on the bottom, and transfer it to a new 96-well plate. In order to quantify Sudan III in the model dirt that can be dissolved in the cleaning solution by immersion cleaning, the absorbance (A500) at 500 nm is measured. The value ΔA500 obtained by subtracting the A500 before cleaning from the A500 after cleaning corresponds to the free amount of oil in the cleaning solution and can be used as an indicator of cleaning power. The cleaning power ΔA500 of each lipase is shown in Figure 3 middle.

[0259] Patent Document 1 discloses that Lipr139, which has adaptability to cleaning, shows higher cleaning power in a model cleaning solution than TLL, Lipr138, PvLip, PfLip, EtLip, EspLip and YeLip. On the other hand, the novel ancestral lipases AncLip1, AncLip3, AncLip4, AncLip5, AncLip6, AncLip7, AncLip8, AncLip9, AncLip10, AncLip11, AncLip12, AncLip13, AncLip14 and AncLip15 show significantly higher cleaning power than Lipr139 in a model cleaning solution.

[0260] A phylogenetic tree was constructed using the amino acid sequences of Lipr139, PvLip, PfLip, EtLip, EspLip, YeLip, AncLip1, AncLip2, AncLip3, AncLip4, AncLip5, AncLip6, AncLip7, AncLip8, and AncLip9 (sequence numbers 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30, respectively). Multiple alignments were performed using clustalW using Genetyx, and a phylogenetic tree was constructed using the neighbor-joining method (NJ method). Figure 4 ).

Claims

1. A lipase, wherein The lipase is any one of the following lipases, A lipase consisting of the amino acid sequence shown in SEQ ID NO: 32 or an amino acid sequence having at least 73% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 14 or an amino acid sequence having at least 79% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 16 or an amino acid sequence having at least 76% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 18 or an amino acid sequence having at least 81% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 20 or an amino acid sequence having at least 83% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 22 or an amino acid sequence having at least 96% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 24 or an amino acid sequence having at least 83% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 26 or an amino acid sequence having at least 90% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 28 or an amino acid sequence having at least 82% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 30 or an amino acid sequence having at least 73% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 34 or an amino acid sequence having at least 79% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 36 or an amino acid sequence having at least 85% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 38 or an amino acid sequence having at least 73% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 40 or an amino acid sequence having at least 71% identity thereto; A lipase consisting of the amino acid sequence shown in SEQ ID NO: 42 or an amino acid sequence having at least 72% identity thereto; and A lipase consisting of the amino acid sequence shown in SEQ ID NO: 44 or an amino acid sequence having at least 70% identity thereto.

2. A polynucleotide, wherein: Encodes the lipase according to claim 1.

3. A vector or DNA fragment, wherein: Comprising the polynucleotide of claim 2.

4. A transformed cell, wherein: Containing the vector or DNA fragment according to claim 3.

5. The transformed cell according to claim 4, wherein The transformed cells are microorganisms.

6. A cleaning composition, wherein: Contains the lipase according to claim 1.

7. The cleaning composition according to claim 6, wherein The detergent composition is a laundry detergent or a dishwashing detergent.

8. The cleaning composition according to claim 7, wherein The cleaning composition is in the form of powder or liquid.

9. The cleaning composition according to claim 7 or 8, wherein Use at low temperatures.

10. The cleaning composition according to claim 9, wherein Use at a temperature between 5 and 40°C.

11. A method for cleaning dirt, wherein: The cleaning composition according to any one of claims 6 to 10 is used.

Citation Information

Patent Citations

  • Bleaching agent composition and bleaching detergent composition

    JP1994316700A

  • Heat-resistant alkaline cellulase, microbe producing the same and its production

    JP1998313859A

  • Powdery detergent composition

    JP2003313592A

  • Lipase-active polypeptides and polynucleotides encoding them

    JP2015523078A

  • Composition containing lipase and method of use thereof

    JP2015525248A